PACS
PACS Group, Inc.
NYSE · Financial Services · Financial - Conglomerates · US
$42.50
−1.31%Year over year
Reported trailing growth
- Revenue
- +15.2%
- EBITDA
- +62.7%
- EBIT
- +83.5%
- EPS
- +100.0%
- Free cash flow
- +56.5%
- Operating cash flow
- +20.3%
Forward estimates
Based on analyst estimates
- Revenue
- +11.6%
- EBITDA
- +57.7%
- EPS
- +47.5%
Three-year CAGR
- Revenue
- +29.7%
- EBITDA
- +12.8%
- EBIT
- +10.5%
- Net income
- +8.4%
- EPS
- +7.1%
- Free cash flow
- +62.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026